100 related articles for article (PubMed ID: 10706395)
1. Failure in antitumor activity by overdose of an immunomodulating beta-glucan preparation, sonifilan.
Miura T; Miura NN; Ohno N; Adachi Y; Shimada S; Yadomae T
Biol Pharm Bull; 2000 Feb; 23(2):249-53. PubMed ID: 10706395
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice.
Ohno N; Miura NN; Chiba N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 Sep; 18(9):1242-7. PubMed ID: 8845814
[TBL] [Abstract][Full Text] [Related]
3. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1-->3)-beta-D-glucan preparation, sonifilan.
Hirata N; Tsuzuki A; Ohno N; Saita M; Adachi Y; Yadomae T
Zentralbl Bakteriol; 1998 Nov; 288(3):403-13. PubMed ID: 9861684
[TBL] [Abstract][Full Text] [Related]
4. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice.
Tsuzuki A; Tateishi T; Ohno N; Adachi Y; Yadomae T
Biosci Biotechnol Biochem; 1999 Jan; 63(1):104-10. PubMed ID: 10052129
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG).
Tsuchiya Y; Igarashi M; Inoue M; Kumagai K
J Pharmacobiodyn; 1989 Oct; 12(10):616-25. PubMed ID: 2534316
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antitumor activities of beta-(1-->6) branched (1-->3)-beta-D-glucan derivatives.
Usui S; Tomono Y; Sakai M; Kiho T; Ukai S
Biol Pharm Bull; 1995 Dec; 18(12):1630-6. PubMed ID: 8787778
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro.
Okazaki M; Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1995 Oct; 18(10):1320-7. PubMed ID: 8593430
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of (1-->3)-beta-D-glucan in mice.
Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory and antitumor activity of schizophyllan under ultrasonic treatment.
Zhong K; Tong L; Liu L; Zhou X; Liu X; Zhang Q; Zhou S
Int J Biol Macromol; 2015 Sep; 80():302-8. PubMed ID: 26126943
[TBL] [Abstract][Full Text] [Related]
10. Synergistic action of beta-glucan and platelets on interleukin-8 production by human peripheral blood leukocytes.
Suzuki T; Tsuzuki A; Ohno N; Ohshima Y; Adachi Y; Yadomae T
Biol Pharm Bull; 2002 Jan; 25(1):140-4. PubMed ID: 11824547
[TBL] [Abstract][Full Text] [Related]
11. The effect of (1-->3)-beta-D-glucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro.
Kubala L; Ruzickova J; Nickova K; Sandula J; Ciz M; Lojek A
Carbohydr Res; 2003 Nov; 338(24):2835-40. PubMed ID: 14667704
[TBL] [Abstract][Full Text] [Related]
12. Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp.
Tokunaka K; Ohno N; Adachi Y; Tanaka S; Tamura H; Yadomae T
Int J Immunopharmacol; 2000 May; 22(5):383-94. PubMed ID: 10708886
[TBL] [Abstract][Full Text] [Related]
13. Blocking effect of anti-Dectin-1 antibodies on the anti-tumor activity of 1,3-beta-glucan and the binding of Dectin-1 to 1,3-beta-glucan.
Ikeda Y; Adachi Y; Ishii T; Tamura H; Aketagawa J; Tanaka S; Ohno N
Biol Pharm Bull; 2007 Aug; 30(8):1384-9. PubMed ID: 17666790
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems.
Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1415-20. PubMed ID: 2142485
[TBL] [Abstract][Full Text] [Related]
15. Preparation and antitumor activities of mitomycin C beta-(1-->6)-branched (1-->3)-beta-D-glucan conjugate.
Usui S; Murashima K; Sakai M; Kiho T; Ukai S
Biol Pharm Bull; 1994 Sep; 17(9):1165-70. PubMed ID: 7841935
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of a particle beta-glucan by proteins in plasma and serum.
Miura T; Ohno N; Miura NN; Shimada S; Yadomae T
Biol Pharm Bull; 1997 Oct; 20(10):1103-7. PubMed ID: 9353573
[TBL] [Abstract][Full Text] [Related]
17. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.
Suzuki Y; Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 2001 Jul; 24(7):811-9. PubMed ID: 11456123
[TBL] [Abstract][Full Text] [Related]
18. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
Sugawara I; Lee KC; Wong M
Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
[TBL] [Abstract][Full Text] [Related]
19. Effects of fungal beta-glucan and interferon-gamma on the secretory functions of murine alveolar macrophages.
Sakurai T; Ohno N; Yadomae T
J Leukoc Biol; 1996 Jul; 60(1):118-24. PubMed ID: 8699115
[TBL] [Abstract][Full Text] [Related]
20. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG).
Inomata T; Goodman GB; Fryer CJ; Chaplin DJ; Palcic B; Lam GK; Nishioka A; Ogawa Y
Br J Cancer Suppl; 1996 Jul; 27():S122-5. PubMed ID: 8763863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
